WPRIM Management System> DCMS> Journal of Experimental Hematology> 2016> 24> 6

Volume: 24 Issue: 6

1. Mechanism of A New DOT1L Inhibitor EPZ-5676 and Its Research Progress -Review. Page:1909—1912
2. Role of Autophagy in Acute Lymphoblastic Leukemia -Review. Page:1905—1908
3. Role of Bone Marrow Mesenchymal Stem Cells in Resistance of Chronic Myeloid Leukemia to Tyrosine Kinase Inhibitors -Review. Page:1901—1904
4. Progress of Experimental Research on Differentiation of Muscle-Derived Stem Cells into Haematopoietic Lineages in Vitro -Review. Page:1897—1900
5. Disorders of Ribosomal Proteins and Related Hematologic Diseases -Review. Page:1892—1896
6. Advances of CRBN in Immunomodulatory Drugs for Multiple Myeloma-Review. Page:1888—1891
7. A New Goal for Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: Treatment-free Remission -Review. Page:1883—1887
8. Arginase Level in Apheresis Leukocyte-Reduced Platelets Stored for Different Time. Page:1879—1882
9. Clinico-pathologic Characteristics of Adult Patients with Atypical Infectious Mononucleosis. Page:1873—1878
10. Effect of Different Hemapheresis Procedures on Components of Hematopoietic Stem Cells Collected from Healthy Donors. Page:1869—1872
11. Effects of Different Culture Systems on the Hematopoietic Differentiation Ability of iPS Cells. Page:1863—1868
12. Reconstruction of Humanized Bone Marrow Niche in Immunodeficiency Mouse. Page:1856—1862
13. Correlation of Thrombosis and Prothrombotic State with Coagulation Factor V Gene Polymorphism and APCR. HHcy. Page:1850—1855
14. Clinical Significance of the Balanceshift of Th1 and Th2 Type Cytokines in Patients with Primary Immune Thrombocytopenic Purpura Detected by Cytometric Bead Array. Page:1846—1849
15. Comparison of Therapeutic Efficacy for Neonatal ABO Hemolytic Disease Treated with Intravenous Immunoglobin G by Different Modes of Administration. Page:1842—1845
16. Significance of Plasma HMGB1, IFN-γ, IL-4 and TLR4 Expression on CD4T Cell Surface in Patients with Immune Thrombocytopenia. Page:1837—1841
17. Role and Significance of T Help Cells 17 in Pathogenesis of Idiopathic Thrombocytopenic Purpura. Page:1833—1836
18. Value of Analyzing Hemoglobin Aby ROC Curve for Screening Thalassemia. Page:1828—1832
19. Effect of Rabbit Anti-human Thymocyte Immunoglobulin Combined with Cyclosporin A on Severe Aplastic Anemia. Page:1824—1827
20. Hematopoietic Reconstitution and Prognosis of HLA Matched and Haploidentical Hematopoietic Stem Cell Transplantation Using Modified FC/ATG Conditioning for Treatment of Severe Aplastic Anemia. Page:1817—1823
21. Clinical Efficacy of Haploidentical Allo-HSCT of Reduced Intensity Preconditioning Combined with Induced Immune Tolerance after Transplantation for Severe Aplastic Anemia. Page:1811—1816
22. Reactivated Expression of MicroRNA-124 in Patients with Myelodysplastic Syndromes after Demethylating Therapy. Page:1807—1810
23. Effect of G Protein-coupled Receptor Kinase 6 on Proliferation and Apoptosis of Multiple Myeloma Cells and Its Mechanisms. Page:1801—1806
24. Construction of Lentiviral Vector Over-Expressing MEG3 and Its Effect on XG-7 Cell Apoptosis. Page:1793—1800
25. Mechanism of Regulating BAFF Signaling Pathway by Act1 in B Cell Lymphoma. Page:1787—1792
26. PET-CT Manifestation and Clinical Analysis of Waldenstrom Macroglobulinemia. Page:1782—1786
27. Clinicopathological Features of Primary Central Nervous System Lymphoma and Their Influence on Prognosis of Desease. Page:1776—1781
28. Analysis of Indicators Related with Cell Proliferation and Apoptosis in the Patients with B Cell Non-Hodgkin's Lymphoma. Page:1771—1775
29. Children's NK/T Cell Lymphoma-Associated Hemophagocytic Syndrome: Clinical Analysis of 6 Cases. Page:1764—1770
30. Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of T Cell Lymphoblastic Lymphoma - Clinical observation of 10 Cases. Page:1759—1763
31. Divergence Analysis of Hepatitis Virus Infection between Aggressive and Indolent B Cell Non-Hodgkin's Lymphoma. Page:1754—1758
32. Clinical Analysis of Adoptive Immunotherapy after Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in B Lymphocyte Malignant Lymphoma. Page:1748—1753
33. Clinical Efficacy of Autologous Hematopoietic Stem Cell Transplantation Using Tumor-ablative Conditioning Regimen for Patients with Refractory/Relapsed Non-Hodgkin's Lymphoma. Page:1743—1747
34. Analysis of Clinical Feature and Treatment Outcome of Patients with Renal Diffuse Large B Cell Lymphoma. Page:1737—1742
35. Therapeutic Efficacy of VICP+L-ASP/TKI on Adult Patients with B-ALL. Page:1730—1736
36. Effects of Arsenic Trioxide on K562 Cell Proliferation and Its Mechanisms. Page:1725—1729
37. Analysis of Therapy and Efficacy after Remission of Acute Myeloid Leukemia. Page:1721—1724
38. Effects of Homoharringtonine Combined with Imatinib on K562 Cell Apoptosis and BCL6 expression. Page:1716—1720
39. Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Proliferation and Differentiation of Leukemia Cells. Page:1710—1715
40. Clinical Analysis of Priming Regimen for Treatment of Acute Myeloid Leukemia (Non-APL) Patients Aged over 70 Years. Page:1705—1709
41. Construction of Eukaryotic Expression Vector of siRNA Specific for BCR/ABL Fusion Gene and Its Effects on K562 Cells. Page:1698—1704
42. Comparison of Ex Vivo Expanded and Highly Purified NK Cell-Mediated Cytotoxicity Detected by 3 Different Staining Methods of Flow Cytometry. Page:1691—1697
43. A Retrospective Study of Ph Negative Adolescent and Young Adults with Acute B Lymphoblastic Leukemia in Two Centers. Page:1683—1690
44. Clinical Characteristics and Prognosis of 21 Cases of Acute Lymphoblastic Leukemia with Central Nervous System Leukemia. Page:1675—1682
45. Effect of WT1 Gene High Expression and CD34and Aueron Prognosis of Acute Myeloid Leukemia. Page:1670—1674
46. hnRNP K Contributes to Adriamycin Resistance in Acute Myeloid Leukemia through Regulating Autophagy. Page:1665—1669
47. Effects of Simvastatin on Expression of Multidrug Resistance Gene and Protein of SHI-1 Cells. Page:1659—1664
48. Effect of BRD4 Inhibitor GSK525762A on Proliferation and Apoptosis of SUP-B15 Cells In Vitro and Its Possible Mechanism. Page:1654—1658
49. Combination of Homoharringtonine with Arsenic Trioxide Induces Apoptosis of Human Acute Myeloid Leukemia Cell Line U937. Page:1649—1653
50. Establishment of Human Chronic Lymphocytic Leukemia Model in the BALB/c Nude Mice by Using MEC-1 and HG3 Cell Lines. Page:1644—1648
51. Role of Non-classical NF-κB Signaling Pathway in B Acute Lymphoblastic Leukemia. Page:1639—1643
52. Expression and Activity Regulation of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells. Page:1633—1638
53. Features of Immunophenotypes and Characteristics of Molecular Biology and Cellular Genetics of AML Patients with CD4 and CD7 Expression. Page:1627—1632
54. Role of NF-κB inhibitor in Acute Myeloid Leukemia. Page:1622—1626
55. FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia. Page:1615—1621